乙醯磺胺酸鉀

GI(Glucose = 100)

0^*0^*

Energy(kcal/100g)

0 kcal^*0 kcal^*

Carbs(g/100g)

0 g^*0 g^*

Sugars(g/100g)

0 g^*0 g^*

功能性益處

還沒有附出處的礦物質或其他功能註記。

已引述的礦物質可在 日常最適合的甜味劑 上最多加 +2 分，見 Methods。

風險與副作用

• 高強度甜味劑

  note

  Use-level and blends matter. Packet fillers are different products. Regulatory class note — not scored.

  FDA — High-intensity sweeteners permitted for use in food (2023)

• WHO 不建議用於體重控制

  caution

  WHO 2023, conditional (low certainty): not for weight control or lowering disease risk — no long-term body-fat benefit. Not a safety ruling. Scored: the energy points it earns over sucrose are taken back on Everyday Health, Weight goals and Easy on the liver; not on Diabetic-friendly (WHO excludes people with diabetes).

  WHO — Use of non-sugar sweeteners: WHO guideline (2023)

• 世代研究發現與冠心病有關聯

  note

  BMJ 2022 NutriNet-Santé (103,388 adults): HR 1.40 (1.06–1.84). Observational association, not proof of cause. Scored: CV signal −7 on Everyday Health and Weight goals (synthetics are not on Diabetic-friendly; not on Easy on the liver), once per sweetener however many links.

  Debras et al. — Artificial sweeteners and risk of cardiovascular diseases: NutriNet-Santé cohort (BMJ) (2022)

• 世代研究發現與癌症有關聯

  note

  PLOS Medicine 2022 NutriNet-Santé (102,865 adults): overall cancer HR 1.13 (1.01–1.26) for higher consumers vs non-consumers. Observational association, not proof of cause; no IARC or JECFA cancer finding for acesulfame K. Scored: cancer signal −7 on every list, Easy on the liver included (synthetics are not on Diabetic-friendly).

  Debras et al. — Artificial sweeteners and cancer risk: NutriNet-Santé cohort (PLOS Medicine) (2022)

這不是醫療建議。若該項目會依公開公式扣分，細節列在「分數怎麼算」；分數不代表臨床嚴重程度。

註記

還沒有額外的背景註記。

註記說明公開軸或風險標籤本身看不出來的事，不是醫療建議。